SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 300 filers reported holding SEATTLE GENETICS INC in Q4 2017. The put-call ratio across all filers is 0.93 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $50,000 | +78.6% | 253 | +53.3% | 0.00% | – |
| Q2 2020 | $28,000 | +180.0% | 165 | +26.9% | 0.00% | – |
| Q1 2019 | $10,000 | -87.7% | 130 | -87.6% | 0.00% | -100.0% |
| Q3 2018 | $81,000 | +211.5% | 1,045 | +109.0% | 0.00% | – |
| Q1 2018 | $26,000 | -3.7% | 500 | 0.0% | 0.00% | – |
| Q4 2017 | $27,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q3 2017 | $27,000 | +440.0% | 500 | +278.8% | 0.00% | – |
| Q1 2016 | $5,000 | +25.0% | 132 | +63.0% | 0.00% | – |
| Q4 2015 | $4,000 | +33.3% | 81 | 0.0% | 0.00% | – |
| Q3 2015 | $3,000 | 0.0% | 81 | +28.6% | 0.00% | – |
| Q2 2015 | $3,000 | -40.0% | 63 | -52.3% | 0.00% | – |
| Q1 2015 | $5,000 | -68.8% | 132 | -64.5% | 0.00% | – |
| Q3 2013 | $16,000 | +23.1% | 372 | -10.8% | 0.00% | – |
| Q2 2013 | $13,000 | -7.1% | 417 | +2.7% | 0.00% | – |
| Q1 2013 | $14,000 | – | 406 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parametrica Management Ltd | 3,581 | $248,000 | 42.18% |
| Baker Brothers Advisors | 50,057,277 | $3,464,464,000 | 23.54% |
| Lagoda Investment Management, L.P. | 76,073 | $5,265,000 | 6.10% |
| Matrix Capital Management Company, LP | 3,141,852 | $217,448,000 | 4.02% |
| DOMINI IMPACT INVESTMENTS LLC | 3,111 | $215,000 | 2.98% |
| Opus Point Partners Management, LLC | 17,901 | $1,239,000 | 1.83% |
| EMORY UNIVERSITY | 33,593 | $2,325,000 | 1.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 60,900 | $4,215,000 | 1.56% |
| Capital International Sarl | 130,400 | $9,025,000 | 1.26% |
| CAPITAL GUARDIAN TRUST CO | 1,303,961 | $90,147,000 | 1.21% |